Today
July 25, 2026Dilution Risk
3Last 7DListing Risk
37Last 30DEarnings
9Last 7DInsider / Ownership
3Last 14DDividends
1Last 30DFDA / Clinical
13Last 30DElong priced a $6.0M unit offering with immediately exercisable $1.30 warrants, implying substantial dilution.
Chip Wilson filed a definitive proxy and detailed settlement talks with lululemon, pressing for board seats and declassification ahead of the 2026 AGM.
Resale registration for 13.02M shares creates urgent dilution and overhang risk.
U.S.-China agreements reopen China to Boeing, commit to rare-earth cooperation, and guarantee large agricultural purchases, easing trade and supply-chain tensions.
United Therapeutics' ralinepag Phase 3 showed 55% reduction in clinical worsening; NDA planned H2 2026.
LiveRamp to be acquired by Publicis Groupe for $38.50 per share in a $2.5 billion all-cash deal.
Nasdaq requires AVX to regain $1 bid price compliance by July 6, 2026; reverse split may be proposed May 29, 2026.
Company faces NYSE American noncompliance and issued large exercisable pre-funded warrants.
Shareholders vote June 22, 2026 on Psyga acquisition, significant ADS issuance, share-cap increase, and financing.
Q1 results: Phase 3 prep progressing, but cash runway is critically low.
MARA won majority consents to amend Long Ridge notes, enabling its planned acquisition pending approvals.
Axe Compute signed a $260M 36-month GPU contract and began compute revenue, targeting Q3 2026 deployment.